Neurogene Inc.

NASDAQ: NGNE · Real-Time Price · USD
20.70
0.50 (2.48%)
At close: Aug 15, 2025, 12:51 PM

Neurogene Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-75.14M -36.32M -55.19M -50.52M
Depreciation & Amortization
3.25M 3.3M 3.2M 947K
Stock-Based Compensation
8.32M 1.42M 1.25M 896K
Other Working Capital
-5.88M -4.69M 912K -1.39M
Other Non-Cash Items
-1.06M -15.69M 608K 679K
Deferred Income Tax
n/a -105K n/a n/a
Change in Working Capital
-5.96M -4.02M -2.69M 1.59M
Operating Cash Flow
-70.6M -51.42M -52.82M -46.4M
Capital Expenditures
-808K -321K -2.23M -18.37M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-198.45M n/a n/a n/a
Sales Maturities Of Investments
74M 5M n/a n/a
Other Investing Acitivies
n/a 20.96M n/a n/a
Investing Cash Flow
-125.26M 25.64M -2.23M -18.37M
Debt Repayment
-52K -29K -1K -51K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-5.47M 168K 73K 338K
Financial Cash Flow
184.07M 92.48M 66.53M 51.06M
Net Cash Flow
-11.79M 66.7M 11.48M -13.71M
Free Cash Flow
-71.41M -51.74M -55.05M -64.77M